genetic familial mutations
492 articles
Felix 2.0 Builds Upon Artificial Intelligence Earlier Detection Successes
Can artificial intelligence help find pancreatic cancer sooner? Dr. Elliot Fishman thinks so, and has been working to make it happen.
Don’t Throw In the Towel
Ashley Coker was dealt a double blow–pancreatic cancer and not qualifying for surgery. She did her research and ended up having a pancreatectomy.
2024 AACR Meeting Update
Some of the highlights of the latest pancreatic cancer research from the 2024 AACR meeting include the mRNA vaccine, and a liquid biopsy.
Helene Andrews-Polymenis, Ph.D., D.V.M.
A native of the Pacific Northwest, Dr. Helene Andrews-Polymenis earned an A.B. in Biology from Brown University (1989), Ph.D. in Molecular Biology/Microbiology from Tufts University (1999), and a D.V.M. from Texas A&M University (TAMU) in 2001. After completing her postdoctoral training, Dr. Andrews-Polymenis joined the faculty in the Department of Microbial and Molecular Pathogenesis at […]
Positive Results For Borderline Resectable Disease Pilot Study
Dr. Zev Wainberg provides details on a trial of chemotherapy and immunotherapy for patients with borderline resectable pancreatic cancer.
Testing a Virus to Help Kill Pancreatic Tumor Cells
Researchers are testing whether cold virus can penetrate the tumor stroma and help kill pancreatic cancer cells.
No Time for Self-Pity
When David Smith started losing weight after a diabetes diagnosis, his daughter-in-law was concerned because she had seen this before.
My Life is Good Now
When Malcolm Robertson was diagnosed with pancreatic cancer, he already knew he carried the BRCA2 mutation.
Targeting a KRAS Variant in Advanced Pancreatic Cancer
Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.
Pancreatic Cancer Pain Management a Zap Away
Dr. Yaacov Lawrence discusses the results of his clinical trial using SBRT radiotherapy for pain management of pancreatic tumors.
Sidney Levinson
Sidney Levinson is a lawyer who specializes in restructuring and special situations. He has practiced for more than 35 years and is currently a partner at Debevoise & Plimpton, a New York-based law firm. He is a fellow in the American College of Bankruptcy and, from 1992 to 1995, served as a trial attorney in […]
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.